BlackRock, Inc. 13D and 13G filings for Krystal Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-08 4:32 pm Purchase |
2024-06-30 | 13G | Krystal Biotech, Inc. KRYS |
BlackRock Inc. BLK |
3,947,588 13.800% |
2,138,211 (+118.17%) |
Filing |
| 2024-01-29 3:26 pm Purchase |
2023-12-31 | 13G | Krystal Biotech, Inc. KRYS |
BlackRock Inc. BLK |
1,809,377 6.400% |
110,952 (+6.53%) |
Filing |
| 2023-01-31 5:52 pm Purchase |
2022-12-31 | 13G | Krystal Biotech, Inc. KRYS |
BlackRock Inc. BLK |
1,698,425 6.600% |
92,929 (+5.79%) |
Filing |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Krystal Biotech, Inc. KRYS |
BlackRock Inc. BLK |
1,605,496 6.400% |
198,148 (+14.08%) |
Filing |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Krystal Biotech, Inc. KRYS |
BlackRock Inc. BLK |
1,407,348 7.100% |
1,407,348 (New Position) |
Filing |